线粒体移植减弱了脂多糖诱导的急性呼吸困扰综合征
Seo-Eun Lee1, In-Hyeon Kim2,3, Young Cheol Kang1
1Paean Biotechnology, Inc. 5 Samil-daero8-gil, Jung-gu, Seoul, 04552, Korea.
BMC pulmonary medicine
|September 28, 2024
概括
线粒体移植显示出治疗急性呼吸困扰综合征 (ARDS) 的前景. 这种疗法减少了ARDS小鼠模型中的肺细胞的炎症和细胞死亡,并减轻了ARDS小鼠模型中的肺损伤.
科学领域:
- 线粒体生物学和再生医学
- 肺部疾病研究研究
- 细胞疗法是一种细胞疗法.
背景情况:
- 线粒体对于细胞能量,炎症和细胞死亡至关重要.
- 线粒体功能障碍与ARDS等疾病有关,这是一种严重的肺部疾病.
- 目前的ARDS治疗缺乏有效性,需要新的治疗策略.
研究的目的:
- 研究线粒体移植在急性呼吸困扰综合征 (ARDS) 的治疗潜力.
- 为了评估外源性线粒体对肺细胞炎症和亡的影响.
- 在ARDS小鼠模型中评估线粒体移植的体内疗效.
主要方法:
- 线粒体从人类干细胞中分离出来.
- 在体外研究中使用LPS诱导的炎症和apoptosis在小鼠膜巨细胞和人类肺微血管内皮细胞.
- 活体疗效在LPS诱导的ARDS小鼠模型中使用静脉线粒体治疗进行了测试.
主要成果:
- 人类干细胞衍生的线粒体对膜巨细胞表现出抗炎作用.
- 这些线粒体还对膜上皮细胞表现出抗亡作用.
- 在ARDS的小鼠模型中,静脉线粒体治疗减轻了肺损伤.
结论:
- 线粒体具有双重的抗炎和抗亡性质.
- 线粒体移植代表了ARDS的有希望的新疗法策略.
- 对ARDS线粒体移植的进一步研究是有必要的.
相关概念视频
Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...


